![NCI Director Monica Bertagnolli has breast cancer “I have more motivation to get up every morning to keep doing what I do”](https://cdn.cancerletter.com/media/2022/12/16120623/48-45-Bertagnolli-4x3-1.jpg)
![NCI Director Monica Bertagnolli has breast cancer “I have more motivation to get up every morning to keep doing what I do”](https://cdn.cancerletter.com/media/2022/12/16120623/48-45-Bertagnolli-4x3-1.jpg)
Cover Story
Conversation with The Cancer LetterFree
By Paul Goldberg and Matthew Bin Han Ong
Monica Bertagnolli, the 16th director of the National Cancer Institute, announced that she will be undergoing treatment for early-stage breast cancer.
In Brief
Funding Opportunities
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence